Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Binusha Moitheennazima , MD

Internal Medicine - Pulmonary Disease • Nacogdoches, TX

Active NPI 1760658330 Individual Practitioner Female Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

1209 N Mound St
Nacogdoches, TX 759614028

Call 9365854646 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1209 N Mound St

Nacogdoches, TX 759614028

Telephone 9365854646
Fax 9365854645
Organization at the Same NPPES Address or Phone
Nacogdoches Pulmonary And Sleep Associates Pa Facility NPI 1558699637

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 2 distinct group names: Nacogdoches Pulmonary And Sleep Associates Pa; Texas Specialty Physicians. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Graduation Year

2000

Medicare patients

878 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $798,447 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $621,872 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

20,840 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$2,436,772 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $7,434.37 across 108 records.

By nature of payment

  • Consulting Fee: $5,076.00 across 3 records.
  • Food and Beverage: $2,234.38 across 103 records.
  • Education: $123.99 across 2 records.

Reporting-company totals (3 largest of 14)

  • AstraZeneca Pharmaceuticals LP: $5,744.75 across 23 records.
  • GlaxoSmithKline, LLC.: $529.44 across 25 records.
  • Verona Pharma, Inc.: $310.51 across 29 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

26 years (graduated 2000)

CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2008

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Moitheennazima has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Moitheennazima as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Nacogdoches and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: 995. Middle half: 375 to 1,872.

Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: $93,554. Middle half: $42,268 to $187,979.

Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: $72,493. Middle half: $32,672 to $145,098.

Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 676 clinicians with data). Median for this group: 762. Middle half: 212 to 1,928.

Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 676 clinicians with data). Median for this group: $429,867. Middle half: $72,110 to $1,195,672.

Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part D data for 2024 to compare.

3 active clinicians are listed under Internal Medicine - Pulmonary Disease with a practice address in Nacogdoches, TX (984 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 108 records totaling $7,434.37.

Manufacturer Payment Nature Product Type Amount ($)
AstraZeneca Pharmaceuticals LP
Consulting Fee
Cash or cash equivalent
— General $1,692.00
AstraZeneca Pharmaceuticals LP
Consulting Fee
Cash or cash equivalent
FASENRA General $1,692.00
AstraZeneca Pharmaceuticals LP
Consulting Fee
Cash or cash equivalent
BREZTRI General $1,692.00
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
BREZTRI General $135.00
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $124.51
JAZZ PHARMACEUTICALS INC.
Education
In-kind items and services
XYWAV General $89.99
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
BREZTRI General $87.84
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
BREZTRI General $63.60
Inspire Medical Systems, Inc.
Food and Beverage
In-kind items and services
INSPIRE General $57.89
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
BREZTRI General $54.56
Viatris Specialty LLC
Food and Beverage
In-kind items and services
YUPELRI General $44.03
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
TEZSPIRE General $41.68
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
BREZTRI General $40.92
Inspire Medical Systems, Inc.
Food and Beverage
In-kind items and services
INSPIRE General $34.10
Amgen Inc.
Education
In-kind items and services
— General $34.00
JAZZ PHARMACEUTICALS INC.
Food and Beverage
In-kind items and services
XYWAV General $31.74
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
OFEV General $31.01
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $29.68
ARS Pharmaceuticals Operations, Inc.
Food and Beverage
In-kind items and services
NEFFY General $28.24
Insmed, Inc.
Food and Beverage
In-kind items and services
Arikayce General $27.36
JAZZ PHARMACEUTICALS INC.
Food and Beverage
In-kind items and services
XYWAV General $27.28
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
TRELEGY ELLIPTA General $27.23
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
OFEV General $26.72
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $26.66
JAZZ PHARMACEUTICALS INC.
Food and Beverage
In-kind items and services
XYWAV General $26.23

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
2,928 689 $437.78 $126.25
95004 Test for allergy using allergenic extract
2,016 28 $13.48 $3.46
94060 Test to measure expiratory airflow and volume changes before and after medication administration
1,107 512 $133.32 $38.04
95165 Professional service for preparation and provision of 1 or more antigens
1,104 23 $53.10 $14.29
J1100 Injection, dexamethasone sodium phosphate, 1 mg
1,100 124 $10.00 $0.11
J0696 Injection, ceftriaxone sodium, per 250 mg
824 106 $4.20 $0.46
95117 Professional service for multiple injections of allergen
545 34 $38.89 $11.89
96372 Injection of drug or substance under skin or into muscle
433 132 $49.15 $14.17
94729 Test to examine how well the lungs exchange gases
379 378 $200.24 $54.18
94726 Test to determine lung volumes using sensors
378 377 $186.31 $53.72
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
378 27 $192.68 $56.50
87804 Detection test by immunoassay with direct visual observation for influenza virus
281 97 $52.00 $16.22
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes
263 50 $354.73 $107.22
95800 Sleep study including heart rate, breathing, and sleep time
251 93 $550.66 $133.25
99291 Critical care, first 30-74 minutes
233 68 $949.97 $212.86
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
202 96 $241.36 $78.80
G0008 Administration of influenza virus vaccine
160 158 $32.00 $30.84
90661 Influenza vaccine, trivalent derived from cell cultures
157 157 $40.00 $35.88
G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)
143 141 $210.95 $62.69
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)
141 97 $125.00 $40.55
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
119 119 $568.23 $166.13
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older)
115 115 $2174.73 $619.37
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
45 43 $670.81 $170.03
95810 Sleep study in sleep lab (6 years or older)
42 42 $2083.24 $585.52
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more
40 39 $558.29 $181.76

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Montelukast Sodium Montelukast Sodium 2,134 100,772 $16,282.59 547
Fluticasone Propionate Fluticasone Propionate 775 35,720 $11,704.72 290
Prednisone Prednisone 624 7,192 $1,788.36 319
Atorvastatin Calcium Atorvastatin Calcium 564 10,325 $6,698.78 58
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter 540 18,090 $385,465.44 149
Albuterol Sulfate Hfa Albuterol Sulfate 496 13,878 $14,815.68 244
Furosemide Furosemide 420 10,726 $2,393.45 68
Potassium Chloride Potassium Chloride 370 9,067 $6,215.90 58
Trazodone Hcl Trazodone Hcl 370 12,348 $3,819.91 74
Levocetirizine Dihydrochloride Levocetirizine Dihydrochloride 322 14,398 $2,742.44 88
Amlodipine Besylate Amlodipine Besylate 316 7,462 $3,105.95 39
Levothyroxine Sodium Levothyroxine Sodium 310 6,762 $3,660.17 44
Gabapentin Gabapentin 297 6,330 $3,392.39 36
Eliquis Apixaban 293 4,984 $103,375.59 30
Advair Hfa Fluticasone Propion/Salmeterol 284 9,210 $100,403.82 92
Symbicort Budesonide/Formoterol Fumarate 274 10,773 $83,994.81 84
Sertraline Hcl Sertraline Hcl 239 4,599 $2,739.38 21
Breo Ellipta Fluticasone/Vilanterol 227 8,040 $104,530.75 53
Breztri Aerosphere Budesonide/Glycopyr/Formoterol 227 7,860 $166,902.25 69
Ventolin Hfa Albuterol Sulfate 217 4,955 $14,301.27 92
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav 215 1,504 $1,848.48 166
Pantoprazole Sodium Pantoprazole Sodium 210 6,358 $4,192.77 39
Mirtazapine Mirtazapine 168 3,165 $2,537.36 19
Escitalopram Oxalate Escitalopram Oxalate 159 3,134 $1,570.37 18
Losartan Potassium Losartan Potassium 157 3,826 $1,950.33 19

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Internal Medicine - Pulmonary Disease Primary Specialty

NUCC Taxonomy Code: 207RP1001X

License # reported to NPPES TX N5256

An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.

Internal Medicine - Critical Care Medicine

NUCC Taxonomy Code: 207RC0200X

License # reported to NPPES TX N5256

An internist who diagnoses, treats and supports patients with multiple organ dysfunction. This specialist may have administrative responsibilities for intensive care units and may also facilitate and coordinate patient care among the primary physician, the critical care staff and other specialists.

Internal Medicine - Sleep Medicine

NUCC Taxonomy Code: 207RS0012X

License # reported to NPPES TX N5256

An Internist who practices Sleep Medicine is certified in the subspecialty of sleep medicine and specializes in the clinical assessment, physiologic testing, diagnosis, management and prevention of sleep and circadian rhythm disorders. Sleep specialists treat patients of any age and use multidisciplinary approaches. Disorders managed by sleep specialists include, but are not limited to, sleep related breathing disorders, insomnia, hypersomnias, circadian rhythm sleep disorders, parasomnias and sleep related movement disorders.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - PULMONARY DISEASE

Medicare Enrollment ID

I20100922000171

Enrollment State Jurisdiction

TX

PECOS Control ID

1759457468

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Nacogdoches Pulmonary And Sleep Associates Pa

1209 N Mound St, Nacogdoches, TX 759614028

Phone: 9365854646

Texas Specialty Physicians

2900 S Loop, Palestine, TX 758016958

Phone: 9037311000

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

2 listed
Tara Bunch , FNP-C

Nurse Practitioner

NPI 1164987715

Family Nurse Practitioner (Certified)

Dr. Ahammed Hashim , MD

Internal Medicine - Pulmonary Disease

NPI 1235134420

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated May 05, 2008.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1760658330
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: May 05, 2008
Last Update: September 12, 2011
Sole Proprietor: No

Other Internal Medicine - Pulmonary Diseases in Nacogdoches

Healthcare providers in Nacogdoches

Mailing Address

Po Box 631310

Nacogdoches, TX 759631310

Phone: 9365854646

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.